MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fonc.2021.609054

Медицинская библиотека · Frontiers in oncology · 2021

Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy.

Trebeschi Stefano, Bodalal Zuhir, Boellaard Thierry N, Tareco Bucho Teresa M, Drago Silvia G, Kurilova Ieva, Calin-Vainak Adriana M, Delli Pizzi Andrea, Muller Mirte, Hummelink Karlijn, Hartemink Koen J, Nguyen-Kim Thi Dan Linh, Smit Egbert F, Aerts Hugo J W L, Beets-Tan Regina G H

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Checkpoint inhibitors provided sustained clinical benefit to metastatic lung cancer patients. Nonetheless, prognostic markers in metastatic settings are still under research. Imaging offers distinctive advantages, providing whole-body information non-invasively, while routinely available in most clinics. We hypothesized that more prognostic information can be extracted by employing artificial intelligence (AI) for treatment monitoring, superior to 2D tumor growth criteria.

METHODS

A cohort of 152 stage-IV non-small-cell lung cancer patients (NSCLC) (73 discovery, 79 test, 903CTs), who received nivolumab were retrospectively collected. We trained a neural network to identify morphological changes on chest CT acquired during patients' follow-ups. A classifier was employed to link imaging features learned by the network with overall survival.

RESULTS

Our results showed significant performance in the independent test set to predict 1-year overall survival from the date of image acquisition, with an average area under the curve (AUC) of 0.69 (p < 0.01), up to AUC 0.75 (p < 0.01) in the first 3 to 5 months of treatment, and 0.67 AUC (p = 0.01) for durable clinical benefit (6 months progression-free survival). We found the AI-derived survival score to be independent of clinical, radiological, PDL1, and histopathological factors. Visual analysis of AI-generated prognostic heatmaps revealed relative prognostic importance of morphological nodal changes in the mediastinum, supraclavicular, and hilar regions, lung and bone metastases, as well as pleural effusions, atelectasis, and consolidations.

CONCLUSIONS

Our results demonstrate that deep learning can quantify tumor- and non-tumor-related morphological changes important for prognostication on serial imaging. Further investigation should focus on the implementation of this technique beyond thoracic imaging.

Для цитирования: Trebeschi Stefano, Bodalal Zuhir, Boellaard Thierry N, Tareco Bucho Teresa M, Drago Silvia G, Kurilova Ieva, Calin-Vainak Adriana M, Delli Pizzi Andrea, Muller Mirte, Hummelink Karlijn, Hartemink Koen J, Nguyen-Kim Thi Dan Linh, Smit Egbert F, Aerts Hugo J W L, Beets-Tan Regina G H. Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy.. Frontiers in oncology. 2021. DOI: 10.3389/fonc.2021.609054.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.